← FDA Drug Approvals (Drugs@FDA)

CEFOTAXIME

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2002-11-20

Drug application

FDA Application #

ANDA065071

Application type

Abbreviated New Drug Application (Generic)

Brand name

CEFOTAXIME

Generic name

CEFOTAXIME

Active ingredients

CEFOTAXIME SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

HIKMA

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2002-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown